Feasibility of dynamic contrast-enhanced MRI (DCE-MRI) based angiogenesis biomarker assessment in advanced NSCLC treated with erlotinib and bevacizumab

被引：0
|
作者：
Scheffler, M. [1 ]
Ullrich, T. [2 ,3 ]
Wetzel, T. [2 ,3 ]
Nogova, L. [4 ]
Zander, T. [4 ]
Mattonet, C. [4 ]
Stoelben, E. [5 ]
Engel-Riedel, W. [5 ]
Tittgemeyer, M. [2 ,3 ]
Wolf, J. [4 ]
机构：
[1] Univ Klinikum Koln BMBF 01KN0706, Innere Med Klin 1, LCGC, Ctr Integrierte Onkol CIO Koln Bonn, Cologne, Germany
[2] Univ Cologne, Fak Med, Cologne, Germany
[3] Max Planck Inst Neurol Res, Klaus Joachim Zulch Lab, Max Planck Gesell, D-50931 Cologne, Germany
[4] Univ Klinikum Koln, Innere Med Klin 1, LCGC, Ctr Integrierte Onkol CIO Koln Bonn, Cologne, Germany
[5] Lungenklin Merheim, Cologne, Germany
来源：
ONKOLOGIE | 2010年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：284 / 284
页数：1
相关论文
共 50 条
  • [1] Comparison of 2 analytical methods of DCE-MRI in advanced NSCLC patients treated with erlotinib and bevacizumab
    van den Boogaart, V. E. M.
    Backes, W.
    De langen, A. J.
    Leffers, P.
    Groen, H. J. M.
    Marcus, J. T.
    Kappert, P.
    Smit, E. F.
    Dingemans, A. C.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S747 - S747
  • [2] Dynamic contrast-enhanced MRI (DCE-MRI) as imaging biomarker in non-small cell lung cancer (NSCLC)
    van den Boogaart, V.
    Smith, E.
    Groen, H.
    Markus, T.
    Kappert, P.
    Backes, W.
    Dingemans, A.
    [J]. EJC SUPPLEMENTS, 2007, 5 (08): : 34 - 34
  • [3] Dynamic Contrast-Enhanced (DCE) MRI
    Li, Xin
    Huang, Wei
    Holmes, James H.
    [J]. MAGNETIC RESONANCE IMAGING CLINICS OF NORTH AMERICA, 2024, 32 (01) : 47 - 61
  • [4] Comparison of Ultrafast Dynamic Contrast-Enhanced (DCE) MRI with Conventional DCE MRI in the Morphological Assessment of Malignant Breast Lesions
    Ohashi, Akane
    Kataoka, Masako
    Iima, Mami
    Honda, Maya
    Ota, Rie
    Urushibata, Yuta
    Nickel, Marcel Dominik
    Toi, Masakazu
    Zackrisson, Sophia
    Nakamoto, Yuji
    [J]. DIAGNOSTICS, 2023, 13 (06)
  • [5] Model selection for analysis of dynamic contrast enhanced MRI (DCE-MRI) data.
    Yankeelov T
    Welch E B
    Chakravarthy B
    Lee R
    Freehardt D
    Mayer, I
    Meszoely, I
    Kelly M
    Means-Powell J
    Gore J
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S45 - S45
  • [6] Biomarker profiling of angiogenesis in breast cancer by immunohistochemistry and dynamic contrast-enhanced MRI
    Chase, D. M.
    Han, E. S.
    Burger, R.
    Randall-Whitis, L.
    Parmakhtlar, B.
    Trapp, V.
    Su, M.
    Nalcioglu, O.
    Mehta, R. S.
    Monk, B. J.
    Fruehauf, J. P.
    [J]. GYNECOLOGIC ONCOLOGY, 2008, 108 (03) : S105 - S105
  • [7] Dynamic contrast enhanced-MRI (DCE-MRI) as a pharmacodynamic biomarker for pazopanib (PZ) in metastatic renal carcinoma (RC).
    Sweis, Randy F.
    Medved, Milica
    Towey, Shannon
    Karczmar, Greg S.
    Oto, Aytekin
    Szmulewitz, Russell Zelig
    O'Donnell, Peter H.
    Fishkin, Paul A. S.
    Stadler, Walter Michael
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [8] Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) evaluation in glioblastoma (GBM) patients treated with bevacizumab (BEV) and irinotecan (CPT-11)
    Desjardins, A.
    Barboriak, D. P.
    Herndon, J. E., II
    Reardon, D. A.
    Quinn, J. A.
    Rich, J. N.
    Sathornsumetee, S.
    Gururangan, S.
    Friedman, H. S.
    Vredenburgh, J. J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [9] Dynamic contrast-enhanced MRI in malignant pleural mesothelioma: prediction of outcome based on DCE-MRI measurements in patients undergoing cytotoxic chemotherapy
    Tomsic, Martina Vivoda
    Korosec, Peter
    Kovac, Viljem
    Bisdas, Sotirios
    Popovic, Katarina Surlan
    [J]. BMC CANCER, 2022, 22 (01)
  • [10] Dynamic contrast-enhanced MRI in malignant pleural mesothelioma: prediction of outcome based on DCE-MRI measurements in patients undergoing cytotoxic chemotherapy
    Martina Vivoda Tomšič
    Peter Korošec
    Viljem Kovač
    Sotirios Bisdas
    Katarina Šurlan Popovič
    [J]. BMC Cancer, 22
12345